Rivaroxaban 10 MG Oral Tablet [Xarelto]

DRUG2 trials

Sponsors

Insel Gruppe AG, University Hospital Bern, Armed Forces Post Graduate Medical Institute (AFPGMI), Rawalpindi

Conditions

Bariatric SurgeryCombined Anticoagulation and Antithrombotic TherapyPAD - Peripheral Arterial Disease

Early Phase 1

Effectiveness of Combined Anticoagulation and Antithrombotic Therapy vs Antithrombotic Therapy Alone After Lower Extremity Revascularization for Peripheral Arterial Disease

Armed Forces Post Graduate Medical Institute (AFPGMI), RawalpindiCombined Anticoagulation and Antithrombotic Therapy, PAD - Peripheral Arterial Disease

Start: 2021-07-02End: 2022-12-30Target: 60Updated: 2022-05-03

Phase 2

Rivaroxaban as Thrombosis Prophylaxis in Bariatric Surgery

CompletedNCT03522259

Insel Gruppe AG, University Hospital BernBariatric Surgery

Start: 2018-07-19End: 2023-12-31Updated: 2024-11-13

Related Papers

Efficacy and Safety of Rivaroxaban for Postoperative Thromboprophylaxis in Patients After Bariatric Surgery

JAMA Network Open2023-05-2520 citations